Author

Jorma J. Palvimo

University of Eastern FinlandORCID 0000-0003-2373-0578Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:differential expression· 2 Research Focus:gene regulatory network inference· 2 Organism:human· 2 Approach:statistical model· 2 Assay:bulk RNA-seq· 1 Assay:ChIP-seq· 1 Assay:DNA methylation· 1 Research Focus:drug response / drug discovery· 1

Frequent Co-Authors

Einari A. NiskaneniD· 2 shared Laura HelmineniD· 2 shared Niina AaltoneniD· 2 shared Ville PaakinahoiD· 2 shared Hanna Laakso· 1 shared Jasmin HuttuneniD· 1 shared Johannes Hiltunen· 1 shared Kaisa‐Mari LaunoneniD· 1 shared

Activity by Year

2023-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 37 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersGenomics

Einari A. NiskanenORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

GenomicsGenome ResearchPeer-reviewedAug 1, 2025

Androgen receptor-mediated assisted loading of the glucocorticoid receptor modulates transcriptional responses in prostate cancer cells

Johannes Hiltunen, Laura Helminen, Niina Aaltonen…·Ville Paakinaho

The paper shows that direct chromatin crosstalk between androgen receptor and glucocorticoid receptor in prostate cancer leads to distinct transcriptional responses associated with improved patient survival.

10 citations

humanbulk RNA-seq

𝕏 PostBluesky

Molecular BiologyNucleic Acids ResearchPeer-reviewedNov 9, 2023

Chromatin Accessibility and Pioneer Factor FOXA1 Shape Glucocorticoid Receptor Action in Prostate Cancer

Laura Helminen, Jasmin Huttunen, Melina Tulonen…·Ville Paakinaho

The paper identifies chromatin pre-accessibility and FOXA1-mediated repression as key regulators of GR action in prostate cancer, offering new strategies to combat antiandrogen resistance.

22 citationstop 5%

humanDNA methylation

𝕏 PostBluesky